Today, FDA authorized the first test to detect Fragile X Syndrome (FXS), the most common known cause of inherited developmental delay & intellectual disability. It ’ s intended as an aid in diagnosing FXS along w/ family history, clinical signs & symptoms.pic.twitter.com/teB7JS5VfZ

Today, FDA authorized the first test to detect Fragile X Syndrome (FXS), the most common known cause of inherited developmental delay & intellectual disability. It’s intended as an aid in diagnosing FXS along w/ family history, clinical signs & symptoms. pic.twitter.com/teB7JS5VfZ

Source: Food and Drug Adminstration (FDA): CDRHNew - February 21, 2020 Category: Medical Devices Authors: ( at US_FDA) Source Type: news